Abstract
Evidence to support the contention that estrogen biosynthesis in breast cancers is of clinical significance has been sought by relating activity to (i) clinical response to aromatase inhibitors and (ii) tumor concentrations of estrogens. Significant correlations have been reported between the presence/high levels of tumor aromatase in vitro and likelihood of response to aminoglutethimide in patients with advanced breast cancer, but the association is not absolute and it has been more difficult to demonstrate similar relationships in patients with earlier stages of cancers treated with other more potent inhibitors. There are however data to suggest that in vitro measurements of aromatase may not reflect in situ estrogen synthesis. For example mammary adipose tissue fibroblasts preincubated with reversible aromatase inhibitors may paradoxically display elevated in vitro aromatase activity. Similar enhanced in vitro activity may be observed in breast material taken from patients treated neo-adjuvantly with aromatase inhibitors such as aminoglutethamide and letrozole. That this is an artifact of in vitro systems can be demonstrated by performing in situ assessments of aromatase activity in patients before and after treatment with aromatase inhibitors. Thus it can be shown that letrozole markedly inhibits in situ aromatase and reduces tumor levels of estrogens.
References
Miller WR: Aromatase activity in breast tissue. J Steroid Biochem Mol Biol 39: 783–790, 1991
Abul-Hajj YJ, Iverson R, Kiang DT: Aromatization of androgens by human breast cancer. Steroids 33: 205–222, 1979
Miller WR, Anderson TJ, Jack WJL: Relationship between tumour aromatase activity, tumour characteristics and response to therapy. J Steroid Biochem Mol Biol 37: 1055–1059, 1990
Bezwoda WR, Mansoor N, Dansey R: Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology 44: 345–349, 1987
Miller WR, O'Neill J: The importance of local synthesis of estrogen within the breast. Steroids 50: 537–538, 1987
Miller WR, Anderson EC: The biological relevance of aromatase activity in breast tumours. In: Robustelli G, Della Cuna, Manni A, Pannutti F (eds) Clinical Use of Aromatase Inhibitors. Current Data and Future Perspectives. Edizioni Medico Scientifiche — Pavia, 1995, pp 89–93
Santen RJ, Santner S, Davis B, Veldhuis J, Smojlik E, Ruby E: Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab 47: 1257–1265, 1978
Murray FT, Santner S, Samojlik E, Santen RJ: Serum aminoglutethimide levels: studies of serum half-life clearance and patient compliance. J Clin Pharmacol 19: 704–711, 1979
Foidart A, Harada N, Balthazart J: Effects of steroidal and non steroidal aromatase inhibitors on sexual behaviour and aromatase-immunoreactive cells and fibers in the quail brain. Brain Res 657: 105–123, 1994
Miller WR, Mullen P: Factors influencing aromatase activity in the breast. J Steroid Biochem Mol Biol 44: 597–604, 1993
Lonning PE: Pharmacology of new aromatase inhibitors. The Breast 5: 202–208, 1996
Reed MJ, Aherne GW, Ghilchik MW, Patel S, Chakraborty J: Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues. Int J Cancer 49: 562–565, 1991
van Landeghem AAJ, Poortman J, Nabuurs M, Thijssen JH: Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45: 2900–2906, 1985
Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC: Aromatase 17β hydroxy-steroid dehydrogenase and intratissular sex hormone concentration in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22: 515–525, 1986
Vermeulen A: Human mammary cancer as a site of sex steroid metabolism. Cancer Surveys 5: 585–595, 1986
Thijssen JHH, Blankenstein MA, Donker GH, Daroszewski J: Endogenous steroid hormones and local aromatase activity in the breast. J Steroid Biochem 39: 799–804, 1991
Miller WR, O'Neill JS: The relevance of local oestrogen metabolism within the breast. Proc Royal Soc Edinburgh 95B: 203–217, 1989
Miller WR: Uptake and synthesis of steroid hormones by the breast. Endocrine Related Cancer 4: 307–311, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, W., Mullen, P., Telford, J. et al. Clinical importance of intratumoral aromatase. Breast Cancer Res Treat 49 (Suppl 1), S27–S32 (1998). https://doi.org/10.1023/A:1006036419833
Issue Date:
DOI: https://doi.org/10.1023/A:1006036419833